McDonough Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-9,414
| Closed | -$272K | – | 49 |
|
2024
Q3 | $272K | Sell |
9,414
-120
| -1% | -$3.47K | 0.19% | 42 |
|
2024
Q2 | $267K | Buy |
9,534
+218
| +2% | +$6.1K | 0.19% | 40 |
|
2024
Q1 | $259K | Buy |
9,316
+108
| +1% | +$3K | 0.2% | 42 |
|
2023
Q4 | $265K | Buy |
9,208
+121
| +1% | +$3.48K | 0.23% | 40 |
|
2023
Q3 | $301K | Sell |
9,087
-170
| -2% | -$5.64K | 0.29% | 35 |
|
2023
Q2 | $340K | Buy |
9,257
+90
| +1% | +$3.3K | 0.31% | 31 |
|
2023
Q1 | $374K | Sell |
9,167
-307
| -3% | -$12.5K | 0.39% | 30 |
|
2022
Q4 | $485K | Buy |
9,474
+66
| +0.7% | +$3.38K | 0.56% | 27 |
|
2022
Q3 | $412K | Buy |
9,408
+73
| +0.8% | +$3.2K | 0.47% | 27 |
|
2022
Q2 | $489K | Sell |
9,335
-23
| -0.2% | -$1.21K | 0.54% | 26 |
|
2022
Q1 | $484K | Buy |
9,358
+68
| +0.7% | +$3.52K | 0.42% | 28 |
|
2021
Q4 | $549K | Buy |
+9,290
| New | +$549K | 0.45% | 28 |
|